iTRAQ-based comparative proteomics analysis reveals specific urinary biomarkers for various kidney diseases

Biomark Med. 2020 Jul;14(10):839-854. doi: 10.2217/bmm-2019-0556. Epub 2020 Aug 28.

Abstract

Background: Proteome studies for multiple renal diseases is bare. Methodology & results: Using isobaric tags for relative and absolute quantitation labeling, many differentially expressed proteins (DEPs) were identified in acute kidney injury (AKI), AKI + chronic kidney disease (CKD), diabetic CKD and nondiabetic CKD with or without IgA nephropathy (IgAN). Comparative analysis indicated that 34, 35, 17, 91 and 14 unique DEPs were found in AKI, AKI + CKD, CKD, diabetic CKD and nondiabetic CKD. Compared with nondiabetic CKD with IgAN, 47 unique DEPs were found in that without IgAN. Serum amyloid A1 (SAA1) and hepatocyte growth factor activator were unregulated in AKI and nondiabetic CKD without IgAN, respectively. Regenerating islet-derived protein 3-α (Reg3A) upregulation is associated with AKI and AKI + CKD patients. Conclusion: This research contributes to urinary biomarker discovery from multiple renal diseases.

Keywords: biomarker discovery; differentially expressed proteins; kidney disease; urinary proteomics.

Publication types

  • Comparative Study

MeSH terms

  • Acute Kidney Injury / diagnosis
  • Acute Kidney Injury / metabolism
  • Acute Kidney Injury / urine
  • Adult
  • Biomarkers* / urine
  • Diabetic Nephropathies / diagnosis
  • Diabetic Nephropathies / metabolism
  • Diabetic Nephropathies / urine
  • Female
  • Glomerulonephritis, IGA / metabolism
  • Glomerulonephritis, IGA / urine
  • Humans
  • Kidney Diseases / diagnosis
  • Kidney Diseases / metabolism
  • Kidney Diseases / urine
  • Male
  • Middle Aged
  • Proteomics* / methods
  • Renal Insufficiency, Chronic / metabolism
  • Renal Insufficiency, Chronic / urine

Substances

  • Biomarkers